Molecular analysis of two uncharacterized sequence variants of the VHL gene

Maddalena Martella, Leonardo Salviati, Alberto Casarin, Eva Trevisson, Giuseppe Opocher, Roberta Polli, David Gross, Alessandra Murgia

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Mutations in the VHL gene cause von Hippel-Lindau disease, a cancer predisposing syndrome characterized by a variety of benign and malignant neoplasms. We report the molecular characterization of two sequence variants of the VHL gene: a synonymous substitution c.462 A>C in exon 2 and a duplication of 11 bp in the promoter region (c.-65_-55dup11). The first variant is a pathogenic mutation because, although it does not change the sense of the affected codon, it causes skipping of exon 2 in the affected allele by altering the splicing consensus site at the 3′ end of exon 2. The 11 bp duplication represents a nonpathogenic variant. In fact, although it affects a critical region of the VHL promoter, it was found in healthy controls, and we show that carrier individuals express both VHL alleles at equimolar levels. Our data underline the importance of careful evaluation of the potential pathogenicity of sequence variants that may not belong to the obvious disease-causing mutation categories, or that affect relevant regulatory regions. mRNA analysis will be required to ultimately resolve this issue.

Original languageEnglish
Pages (from-to)964-968
Number of pages5
JournalJournal of Human Genetics
Volume51
Issue number11
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Exons
Genetic Promoter Regions
Mutation
Alleles
Genes
von Hippel-Lindau Disease
Nucleic Acid Regulatory Sequences
Codon
Virulence
Neoplasms
Messenger RNA

Keywords

  • Duplication
  • mRNA
  • Polymorphism
  • Promoter
  • Silent mutation
  • VHL

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Martella, M., Salviati, L., Casarin, A., Trevisson, E., Opocher, G., Polli, R., ... Murgia, A. (2006). Molecular analysis of two uncharacterized sequence variants of the VHL gene. Journal of Human Genetics, 51(11), 964-968. https://doi.org/10.1007/s10038-006-0054-9

Molecular analysis of two uncharacterized sequence variants of the VHL gene. / Martella, Maddalena; Salviati, Leonardo; Casarin, Alberto; Trevisson, Eva; Opocher, Giuseppe; Polli, Roberta; Gross, David; Murgia, Alessandra.

In: Journal of Human Genetics, Vol. 51, No. 11, 11.2006, p. 964-968.

Research output: Contribution to journalArticle

Martella, M, Salviati, L, Casarin, A, Trevisson, E, Opocher, G, Polli, R, Gross, D & Murgia, A 2006, 'Molecular analysis of two uncharacterized sequence variants of the VHL gene', Journal of Human Genetics, vol. 51, no. 11, pp. 964-968. https://doi.org/10.1007/s10038-006-0054-9
Martella, Maddalena ; Salviati, Leonardo ; Casarin, Alberto ; Trevisson, Eva ; Opocher, Giuseppe ; Polli, Roberta ; Gross, David ; Murgia, Alessandra. / Molecular analysis of two uncharacterized sequence variants of the VHL gene. In: Journal of Human Genetics. 2006 ; Vol. 51, No. 11. pp. 964-968.
@article{93444ccf8d7a46e48c58a76c33bde2b9,
title = "Molecular analysis of two uncharacterized sequence variants of the VHL gene",
abstract = "Mutations in the VHL gene cause von Hippel-Lindau disease, a cancer predisposing syndrome characterized by a variety of benign and malignant neoplasms. We report the molecular characterization of two sequence variants of the VHL gene: a synonymous substitution c.462 A>C in exon 2 and a duplication of 11 bp in the promoter region (c.-65_-55dup11). The first variant is a pathogenic mutation because, although it does not change the sense of the affected codon, it causes skipping of exon 2 in the affected allele by altering the splicing consensus site at the 3′ end of exon 2. The 11 bp duplication represents a nonpathogenic variant. In fact, although it affects a critical region of the VHL promoter, it was found in healthy controls, and we show that carrier individuals express both VHL alleles at equimolar levels. Our data underline the importance of careful evaluation of the potential pathogenicity of sequence variants that may not belong to the obvious disease-causing mutation categories, or that affect relevant regulatory regions. mRNA analysis will be required to ultimately resolve this issue.",
keywords = "Duplication, mRNA, Polymorphism, Promoter, Silent mutation, VHL",
author = "Maddalena Martella and Leonardo Salviati and Alberto Casarin and Eva Trevisson and Giuseppe Opocher and Roberta Polli and David Gross and Alessandra Murgia",
year = "2006",
month = "11",
doi = "10.1007/s10038-006-0054-9",
language = "English",
volume = "51",
pages = "964--968",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Molecular analysis of two uncharacterized sequence variants of the VHL gene

AU - Martella, Maddalena

AU - Salviati, Leonardo

AU - Casarin, Alberto

AU - Trevisson, Eva

AU - Opocher, Giuseppe

AU - Polli, Roberta

AU - Gross, David

AU - Murgia, Alessandra

PY - 2006/11

Y1 - 2006/11

N2 - Mutations in the VHL gene cause von Hippel-Lindau disease, a cancer predisposing syndrome characterized by a variety of benign and malignant neoplasms. We report the molecular characterization of two sequence variants of the VHL gene: a synonymous substitution c.462 A>C in exon 2 and a duplication of 11 bp in the promoter region (c.-65_-55dup11). The first variant is a pathogenic mutation because, although it does not change the sense of the affected codon, it causes skipping of exon 2 in the affected allele by altering the splicing consensus site at the 3′ end of exon 2. The 11 bp duplication represents a nonpathogenic variant. In fact, although it affects a critical region of the VHL promoter, it was found in healthy controls, and we show that carrier individuals express both VHL alleles at equimolar levels. Our data underline the importance of careful evaluation of the potential pathogenicity of sequence variants that may not belong to the obvious disease-causing mutation categories, or that affect relevant regulatory regions. mRNA analysis will be required to ultimately resolve this issue.

AB - Mutations in the VHL gene cause von Hippel-Lindau disease, a cancer predisposing syndrome characterized by a variety of benign and malignant neoplasms. We report the molecular characterization of two sequence variants of the VHL gene: a synonymous substitution c.462 A>C in exon 2 and a duplication of 11 bp in the promoter region (c.-65_-55dup11). The first variant is a pathogenic mutation because, although it does not change the sense of the affected codon, it causes skipping of exon 2 in the affected allele by altering the splicing consensus site at the 3′ end of exon 2. The 11 bp duplication represents a nonpathogenic variant. In fact, although it affects a critical region of the VHL promoter, it was found in healthy controls, and we show that carrier individuals express both VHL alleles at equimolar levels. Our data underline the importance of careful evaluation of the potential pathogenicity of sequence variants that may not belong to the obvious disease-causing mutation categories, or that affect relevant regulatory regions. mRNA analysis will be required to ultimately resolve this issue.

KW - Duplication

KW - mRNA

KW - Polymorphism

KW - Promoter

KW - Silent mutation

KW - VHL

UR - http://www.scopus.com/inward/record.url?scp=33751273857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751273857&partnerID=8YFLogxK

U2 - 10.1007/s10038-006-0054-9

DO - 10.1007/s10038-006-0054-9

M3 - Article

VL - 51

SP - 964

EP - 968

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 11

ER -